Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer

Sponsor
SCRI Development Innovations, LLC
Study ID
NCT00193362
Phase
PHASE3
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Paclitaxel — DRUG
  • Carboplatin — DRUG
  • Gemcitabine — DRUG
  • Vinorelbine — DRUG

Study Details

The purpose of this study is to compare the effectiveness of the three-drug combination paclitaxel, carboplatin, and gemcitabine to the two-drug combination gemcitabine and vinorelbine in patients with advanced Non-Small Cell Lung Cancer

Key Dates

Start date
Jun 30, 2004
Status verified
Jul 2010
Primary completion
Jun 30, 2005
Completion
Sep 30, 2007

Study Design

Enrollment
200 participants
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

Overall survival.

Related Studies